Metastatic intrahepatic cholangiocarcinoma
Clinical trials for Metastatic intrahepatic cholangiocarcinoma explained in plain language.
Never miss a new study
Get alerted when new Metastatic intrahepatic cholangiocarcinoma trials appear
Sign up with your email to follow new studies for Metastatic intrahepatic cholangiocarcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a Four-Drug cocktail outsmart bile duct cancer?
Disease control Recruiting nowThis phase II trial is testing whether alternating standard chemotherapy and immunotherapy with a targeted drug called pemigatinib can help people with advanced biliary tract cancers that have FGFR2 alterations. The study includes adults with cancer that cannot be removed by surg…
Matched conditions: METASTATIC INTRAHEPATIC CHOLANGIOCARCINOMA
Phase 2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Triple therapy takes on bile duct cancer: hope for unresectable cases
Disease control Recruiting nowThis phase 2 trial is testing a combination of radiation beads (Y-90), immunotherapy (durvalumab), and chemotherapy (gemcitabine and cisplatin) in 30 people with advanced bile duct cancer that cannot be removed surgically. The goal is to see if this mix can slow cancer growth and…
Matched conditions: METASTATIC INTRAHEPATIC CHOLANGIOCARCINOMA
Phase 2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC